We are live on
!
Find out more
LDNAM
Lepercq De Neuflize Asset Management Portfolio holdings
AUM
$158M
1-Year Est. Return
20.61%
This Fund
S&P 500
This Quarter
Est. Return
+10.06%
1 Year Est. Return
+20.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$48.3M
(+47%)
Cap. Flow
+$769K
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
16
New
2
Increased
5
Reduced
–
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qorvo
QRVO
|
+$989K |
| 2 |
Clarus
CLAR
|
+$33.9K |
| 3 |
Wetouch Technology
WETH
|
+$10.4K |
| 4 |
LVTX
LAVA Therapeutics
LVTX
|
+$10.2K |
| 5 |
Presidio Property Trust
SQFT
|
+$5.72K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lifecore Biomedical
LFCR
|
+$139K |
| 2 |
ENZ
Enzo Biochem, Inc.
ENZ
|
+$57.8K |
| 3 |
AN2 Therapeutics
ANTX
|
+$31.6K |
| 4 |
Barnwell Industries
BRN
|
+$24.3K |
| 5 |
Deswell Industries
DSWL
|
+$23.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 98.91% |
| 2 | Technology | 0.82% |
| 3 | Healthcare | 0.15% |
| 4 | Consumer Discretionary | 0.07% |
| 5 | Real Estate | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
State Street SPDR S&P 500 ETF Trust
SPY
$795B
| $71.2M | 46.97% |
115,245
| – | – |
|
2
iShares MSCI EAFE ETF
EFA
$77.6B
| $41.7M | 27.48% |
466,000
| – | – |
|
|
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$795B
| $37.1M | 24.46% |
+60,000
| New | +$34.3M |
|
|
4
Qorvo
QRVO
$10.1B
| $1.16M | 0.77% |
+13,700
| New | +$989K |
|
|
XYLO
5
DELISTED
Xylo Technologies
XYLO
| $132K | 0.09% |
26,059
| – | – |
|
|
6
Clarus
CLAR
$136M
| $112K | 0.07% |
32,200
+10,000
| +45% | +$33.9K |
|
|
7
Presidio Property Trust
SQFT
$1.85M
| $75.4K | 0.05% |
14,412
+999
| +7% | +$5.72K |
|
|
8
Wetouch Technology
WETH
$15.4M
| $74K | 0.05% |
77,954
+10,000
| +15% | +$10.4K |
|
|
EPIX
9
DELISTED
ESSA Pharma
EPIX
| $57.3K | 0.04% |
33,700
+2,000
| +6% | +$3.37K |
|
|
LVTX
10
DELISTED
LAVA Therapeutics
LVTX
| $40.9K | 0.03% |
31,000
+8,000
| +35% | +$10.2K |
|
|
11
AN2 Therapeutics
ANTX
$202M
| – | – |
-23,234
| Closed | -$31.6K |
|
|
12
Barnwell Industries
BRN
$14.4M
| – | – |
-15,000
| Closed | -$24.3K |
|
|
13
Deswell Industries
DSWL
$49.2M
| – | – |
-10,000
| Closed | -$23.6K |
|
|
14
Lifecore Biomedical
LFCR
$157M
| – | – |
-19,700
| Closed | -$139K |
|
|
LGL.WS
15
DELISTED
LGL Group Inc Warrants
LGL.WS
| – | – |
-26,200
| Closed | -$8.38K |
|
|
ENZ
16
DELISTED
Enzo Biochem, Inc.
ENZ
| – | – |
-156,303
| Closed | -$57.8K |
|
Similar funds
BCI
AWMG
SFSG
APW
CM
PTFIS
TC
CAG
Lepercq De Neuflize Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Lepercq De Neuflize Asset Management held 16 positions worth $152M, up 47% from $103M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Lepercq De Neuflize Asset Management's Q2 2025 filing shows 2 new, 5 increased and 6 closed positions. Its largest new stake was Qorvo: 13,700 shares worth $1.16M. The largest sale was Lifecore Biomedical, an estimated $139K.
By sector, the portfolio is most concentrated in Miscellaneous at 99% of assets, down from 99% a quarter earlier, followed by Technology and Healthcare.
- Lepercq De Neuflize Asset Management's largest Q2 2025 buy was Qorvo: 13,700 shares worth $1.16M.
- Lepercq De Neuflize Asset Management added most to Clarus in Q2 2025, an estimated $33.9K increase.
- Lepercq De Neuflize Asset Management fully exited Lifecore Biomedical in Q2 2025, selling an estimated $139K.
- Lepercq De Neuflize Asset Management's ten largest holdings make up 100% of its $152M portfolio in Q2 2025.
- Lepercq De Neuflize Asset Management opened 2 new positions and closed 6 in Q2 2025.
- Lepercq De Neuflize Asset Management's portfolio value rose 47% quarter-over-quarter to $152M.
Based on Lepercq De Neuflize Asset Management's 13F filing for Q2 2025, filed 11 Aug 2025.